Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Monge, Marta; Doll, Andreas; Colas, Eva; Gil-Moreno, Antonio; Castellvi, Josep; Garcia, Angel; Colome, Nuria; Perez-Benavente, Asummpcio; Pedrola, Nuria; Lopez-Lopez, Rafael; Dolcet, Xavier; Ramon y Cajal, Santiago; Xercavins, Jordi; Matias-Guiu, Xavier; Canals, Francesc; Reventos, Jaume; Abal, Miguel

    Subtractive proteomic approach to the endometrial carcinoma invasion front.

    JOURNAL OF PROTEOME RESEARCH 8 4676-4684. .

    [doi:10.1021/pr900390t]

  • Landa, Inigo; Ruiz-Llorente, Sergio; Montero-Conde, Cristina; Inglada-Perez, Lucia; Schiavi, Francesca; Leskelae, Susanna; Pita, Guillermo; Milne, Roger; Maravall, Javier; Ramos, Ignacio; Andia, Victor; Rodriguez-Poyo, Paloma; Jara-Albarran, Antonino; Meoro, Amparo; del Peso, Cristina; Arribas, Luis; Iglesias, Pedro; Caballero, Javier; Serrano, Joaquin; Pico, Antonio; Pomares, Francisco; Gimenez, Gabriel; Lopez-Mondejar, Pedro; Castello, Roberto; Merante-Boschin, Isabella; Pelizzo, Maria-Rosa; Mauricio, Didac; Opocher, Giuseppe; Rodriguez-Antona, Cristina; Gonzalez-Neira, Anna; Matias-Guiu, Xavier; Santisteban, Pilar; Robledo, Mercedes

    The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.

    Plos Genetics 5 -. .

    [doi:10.1371/journal.pgen.1000637]

  • Llobet, D.; Pallares, J.; Yeramian, A.; Santacana, M.; Eritja, N.; Velasco, A.; Dolcet, X.; Matias-Guiu, X.

    Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.

    JOURNAL OF CLINICAL PATHOLOGY 62 777-785. .

    [doi:10.1136/jcp.2008.056101]

  • Pallares, Judit; Santacana, Maria; Puente, Soraya; Lopez, Susana; Yeramian, Andree; Eritja, Nuria; Sorolla, Anabel; Llobet, David; Dolcet, Xavier; Matias-Guiu, Xavier

    A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma.

    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY 31 217-226. .

  • Ferran, M.; Bussaglia, E.; Matias-Guiu, X.; Pujol, R. M.

    Bilateral and symmetrical palmoplantar punctate keratoses in childhood: a possible clinical clue for an early diagnosis of PTEN hamartoma-tumour syndrome

    CLINICAL AND EXPERIMENTAL DERMATOLOGY 34 28-30. .

    [doi:10.1111/j.1365-2230.2008.03136.x]

  • Cascon, Alberto; Pita, Guillermo; Burnichon, Nelly; Landa, Igo; Lopez-Jimenez, Elena; Montero-Conde, Cristina; Leskelae, Susanna; Javier Leandro-Garcia, Luis; Leton, Rocio; Rodriguez-Antona, Cristina; Angel Diaz, Jose; Lopez-Vidriero, Emilio; Gonzalez-Neira, Anna; Velasco, Ana; Matias-Guiu, Xavier; Gimenez-Roqueplo, Anne-Paule; Robledo, Mercedes

    Genetics of Pheochromocytoma and Paraganglioma in Spanish Patients

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 94 1701-1705. .

    [doi:10.1210/jc.2008-2756]

  • Pallares, Judit; Llobet, David; Santacana, Maria; Eritja, Nuria; Velasco, Ana; Cuevas, Dolors; Lopez, Susana; Palomar-Asenjo, Victor; Yeramian, Andree; Dolcet, Xavier; Matias-Guiu, Xavier

    CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

    AMERICAN JOURNAL OF PATHOLOGY 174 287-296. .

    [doi:10.2353/ajpath.2009.080552]

  • Brieva-Ruiz, L.; Diaz-Hurtado, M.; Matias-Guiu, X.; Marquez-Medina, D.; Tarragona, J.; Garus, F.

    Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.

    CLINICAL NEUROLOGY AND NEUROSURGERY 110 1044-1046. .

    [doi:10.1016/j.clineuro.2008.06.016]

  • Ortega, Eugenia; Marti, Rosa M.; Yeramian, Andree; Sorolla, Anabel; Dolcet, Xavier; Llobet, David; Abal, Leandro; Santacana, Maria; Pallares, Judit; Llombart-Cussac, Antonio; Matias-Guiu, Xavier

    Targeted therapies in gynecologic cancers and melanoma.

    SEMIN DIAGN PATHOL 25 262-273. .

    [doi:10.1053/j.semdp.2008.07.008]

  • Puente, Soraya; Velasco, Ana; Gallel, Pilar; Pallares, Judit; Perez-Ruiz, Luis; Ros, Susana; Maravall, Javier; Matias-Guiu, Xavier

    Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder.

    ENDOCRINE PATHOLOGY 19 190-196. .

    [doi:10.1007/s12022-008-9024-4]

  • Gallel, Pitar; Pallares, Judit; Dolcet, Xavier; Llobet, David; Eritja, Nuria; Santacana, Maria; Yeramian, Andre; Palomar-Asenjo, Victor; Lagarda, Helena; Mauricio, Didac; Encinas, Mario; Matias-Guiu, Xavier

    Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.

    HUMAN PATHOLOGY 39 994-1001. .

    [doi:10.1016/j.humpath.2007.11.015]

  • Velasco A; Pallares J; Santacana M; Yeramian A; Dolcet X; Eritja N; Puente S; Sorolla A; Llecha N; Matias-Guiu X

    Loss of heterozygosity in endometrial carcinoma.

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 27 305-317. .

    [doi:10.1097/PGP.0b013e31815daf1a]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU